- Home
- BDTX vs RCMT Comparison
BDTX vs RCMT Comparison
Compare BDTX & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- RCMT
- Stock Information
- Founded
- BDTX 2014
- RCMT 1971
- Country
- BDTX United States
- RCMT United States
- Employees
- BDTX N/A
- RCMT N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- RCMT Professional Services
- Sector
- BDTX Health Care
- RCMT Consumer Discretionary
- Exchange
- BDTX Nasdaq
- RCMT Nasdaq
- Market Cap
- BDTX 220.3M
- RCMT 200.2M
- IPO Year
- BDTX 2020
- RCMT N/A
- Fundamental
- Price
- BDTX $3.95
- RCMT $23.13
- Analyst Decision
- BDTX Strong Buy
- RCMT Strong Buy
- Analyst Count
- BDTX 5
- RCMT 2
- Target Price
- BDTX $10.40
- RCMT $33.50
- AVG Volume (30 Days)
- BDTX 812.4K
- RCMT 30.5K
- Earning Date
- BDTX 11-05-2025
- RCMT 11-05-2025
- Dividend Yield
- BDTX N/A
- RCMT N/A
- EPS Growth
- BDTX N/A
- RCMT N/A
- EPS
- BDTX 0.25
- RCMT 1.76
- Revenue
- BDTX $70,000,000.00
- RCMT $299,916,000.00
- Revenue This Year
- BDTX N/A
- RCMT $15.03
- Revenue Next Year
- BDTX N/A
- RCMT $7.49
- P/E Ratio
- BDTX $15.76
- RCMT $13.13
- Revenue Growth
- BDTX N/A
- RCMT 11.01
- 52 Week Low
- BDTX $1.20
- RCMT $13.18
- 52 Week High
- BDTX $4.45
- RCMT $28.27
- Technical
- Relative Strength Index (RSI)
- BDTX 55.41
- RCMT 42.77
- Support Level
- BDTX $3.71
- RCMT $22.20
- Resistance Level
- BDTX $4.08
- RCMT $23.46
- Average True Range (ATR)
- BDTX 0.24
- RCMT 0.81
- MACD
- BDTX -0.04
- RCMT 0.09
- Stochastic Oscillator
- BDTX 35.90
- RCMT 53.72
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.